Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioactive Dietary Polyphenol Preparation (BDPP) is a specific nutraceutical formulation composed of Concord grape juice (CGJ), grape seed polyphenol extract (GSPE), and trans-resveratrol (RSV). It is designed to deliver a specific profile of bioavailable polyphenol metabolites, such as dihydrocaffeic acid (DHCA), quercetin-3-O-glucuronide, and malvidin-3-O-glucoside, which are capable of crossing the blood-brain barrier. BDPP is being investigated for its neuroprotective and anti-inflammatory properties, specifically its ability to modulate neuroinflammation through the inhibition of pro-inflammatory cytokines like IL-6 and TNF-α and the HMGB1-RAGE signaling pathway. Furthermore, it has been shown to promote cognitive resilience and synaptic plasticity by activating the VGF-BDNF autoregulatory loop and the mTOR/CREB signaling pathways. The preparation is being studied for various conditions, including depression, anxiety, mild cognitive impairment (MCI), Alzheimer's disease, and sleep deprivation-induced cognitive dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bioactive dietary polyphenol preparation.